Alpna Seth Power - 01 May 2023 Form 3 Insider Report for Keros Therapeutics, Inc. (KROS)

Role
Director
Signature
/s/ Keith Regnante, Attorney-in-Fact
Issuer symbol
KROS
Transactions as of
01 May 2023
Net transactions value
$0
Form type
3
Filing time
03 May 2023, 16:44:14 UTC
Previous filing
31 Oct 2022
Next filing
02 Jun 2023

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit List - Exhibit 24 - Power of Attorney